Reduced frequency dosing of osimertinib in EGFR-mutant non-small cell lung carcinoma: real world data.

Autor:	Noronha, Vanita1, Sahu, Harsh1, Kapoor, Akhil2, Patil, Vijay3, Menon, Nandini1, Shah, Minit1, Davis, Dilan1, Roy, Rumeli1, Vivek, Srigadha1, Janu, Amit4, Kaushal, Rajiv5, Prabhash, Kumar1 kumarprabhashtmh@gmail.com
Zdroj:	Ecancermedicalscience. 2024, Vol. 18 Issue 1676-1753, p1-13. 13p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu